At-Home Drug of Abuse (DOA) Testing Market Size to Reach $831.9 million by 2023: P&S Intelligence

New York, New York, UNITED STATES

NEW YORK, Sept. 17, 2018 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Intelligence, global at-home DOA testing market is projected to attain a size of $831.9 million by 2023. The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.

Request to get the sample pages:

On the basis of various types of products, the at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers. The market for rapid DOA test kits is expected to witness faster growth during the forecast period, attributed to the increasing adoption of various types of rapid DOA test kits, including test cups and dip cards. Also, these test kits are much cheaper as compared to breath analyzers.

Further, the rapid DOA test kits are bifurcated into test cups, test strips, test dip cards, and other types of kits. Amongst all these, the DOA test cups dominated the global rapid DOA test kits market in 2017. Extensive use of test cups for at-home urine drug testing is a key factor driving the market for this product category.

Browse report overview with 135 tables and 47 figures spread through 168 pages and detailed TOC on "At-Home Drug of Abuse (DOA) Testing Market by Product (Rapid DOA Test Kits [Test Cups, Test Dip Cards, Test Strips], Breath Analyzers), by Sample (Urine, Saliva, Hair), by Geography (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Australia, Brazil, Mexico, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023" at:

Samples used for at-home DOA testing are urine, saliva, hair, and other different types of samples. Of these, the products using urine as a sample are expected to witness the fastest growth in the at-home DOA testing market during the forecast period. DOA detection through urine sample is the easiest and most affordable way of at-home DOA testing. It is, therefore, the most commonly used method to analyze the presence of illegal and prescribed drugs in the body.

During the forecast period, the at-home DOA testing market is forecasted to witness the fastest growth in APAC, at a CAGR of 11.0%. This growth is attributed to the rising consumption of illicit drugs in the region. Also, the region is a large producer and trader of illicit drugs, including opium, heroin, amphetamine-type stimulants (ATS), and methamphetamines.

Make enquiry before buying the report:

The companies operating in the at-home DOA testing industry are acquiring other firms and establishing their presence in different economies to increase their market share. Abbott Laboratories (Abbott) being a major player in the production of at-home DOA testing products acquired Alere Inc. in 2017, to increase its share in the point-of-care testing diagnostics market. The addition of this business aligns with Abbott's strategy for the growth of company and complements the leadership positions across its other businesses, which include medical devices, nutritional supplements, and pharmaceuticals.

Some of the other key players in the at-home DOA testing industry are UCP Biosciences Inc., Orient New Life Medical Co. Ltd., Express Diagnostics Int’l Inc., Assure Tech (Hangzhou) Co. Ltd., Psychemedics Corporation, Confirm BioSciences, Phamatech Inc., Home Health (U.K.) Ltd., and Quest Products Inc.

Browse Other Published Report by P&S Intelligence

Drug of Abuse (DOA) Testing Market

North America has been the largest market for drug of abuse testing market, with the U.S. being the larger contributor to the regional market, as compared to rest of North America. The leading position of the North American market is mainly due to the increased availability of illicit drugs, rising workplace monitoring for consumption of illicit drugs and increased drug trafficking in the region.

Anti-Aging Market

European anti-aging industry is set to cross $85.7 billion by 2025, growing at a CAGR of 7.8% between 2017-2025. The anti-aging industry in Europe is witnessing a significant growth mainly due to increase in product approvals, rise in volume of surgical and non-surgical aesthetic procedures, and increase in aging population. In 2016, Germany held the largest share of the European anti-aging market, standing at 25.2%. Increase in the volume of surgical and non-surgical cosmetic procedures in Germany due to its increasing awareness is driving the growth of the market.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.


P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455



Connect with us: LinkedIn | Twitter | Google + | Facebook